https://www.globenewswire.com/news-release/2024/07/18/2915008/0/en/BioSenic-releases-new-in-depth-analysis-of-its-positive-phase-2-clinical-data-for-optimal-administration-scheme-for-its-next-late-stage-trial-of-arsenic-trioxide-ATO-targeting-cGvH.html
BioSenic releases new in-depth analysis of its positive
Press Release The upcoming Phase 3 trial with ATO is more robust following a new post-hoc analysis. Mont-Saint-Guibert, Belgium, July 18, 2024, 7.00 am...
in depth analysisreleases newpositive